LifeSciences2030 invests collaboratively with partners in early stage companies and start-ups.
Our start-ups generate highly attractive returns. Our concept envisages that the capital with the greatest risk of default (pre-seed) comes from the company builder.
We are life science experts and are actively involved in our start-ups.
With us, founders can flexibly integrate the best possible experts – thereby turning fixed costs into variable costs and efficiently achieving outstanding results. Knowledge management is generally our ultimate goal: we coach and advise our founders and share our knowledge with our start-ups.